Research programme: human beta defensin conjugates - Sci-Engi- Medco SolutionsAlternative Names: hBD-1/MMP-2 cleavable peptides; human beta defensin-1/matrix metalloproteinase-2 cleavable peptides
Latest Information Update: 10 Aug 2016
At a glance
- Originator Sci-Engi-Medco Solutions
- Class Peptides
- Mechanism of Action Apoptosis stimulants; Beta defensin modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 10 Aug 2016 Early research in Cancer in USA (unspecified route)